Protein S is a vitamin K-dependent glycoprotein cofactor to the serine protease, activated protein C. In this study we demonstrate that '25I-protein S bound to unstimulated platelets in a time-and calcium-dependent saturable reaction. Half-maximal binding occurred at a protein S concentration of 10 nM, with -1,100 binding sites per platelet. The binding of protein S to platelets was followed by rapid cleavage of the protein mediated by a protease confined to the platelet membrane.
Introduction
Protein S is a vitamin K-dependent glycoprotein cofactor to the serine protease activated protein C (APC)' (1) . The latter is an anticoagulant, which inactivates Factors Va and Villa in a Ca+-and lipid-dependent reaction (2) . Deficiency of either protein C or S has recently been reported to be associated with recurrent venous thrombosis in humans (3, 4) . Current evidence indicates that Protein S forms a 1:1 complex with APC that results in the increased affinity ofAPC for the platelet or phospholipid surface (5, 6) .
The regulation of protein S activity in plasma is thought to be by thrombin, which cleaves the protein near the amino terminal end of the molecule, with subsequent loss of cofactor activity (7) (8) (9) . There is some evidence that this event is unlikely to be a major control mechanism for the anticoagulant activity of protein S, because the reaction is inhibited by physiological Ca"+ concentrations, and by the endothelial surface protein thrombomodulin (unpublished observation). The role of platelets in the modulation of protein S activity has yet to be fully elucidated.
1. Abbreviations used in this paper: APC, activated protein C; AT III, antithrombin III; NEM, N-ethyl maleimide; PAGE, polyacrylamide gel electrophoresis; PGE,, prostaglandin El; PMSF, phenyl methyl sulphonyl fluoride.
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In this study we examined the binding ofprotein S to platelets and its effect on the anticoagulant activity of the protein. Our results indicate that the binding ofprotein S to platelets is rapidly followed by its proteolysis and the loss of cofactor activity.
Methods
All chemicals, were purchased from Sigma Chemical Co. (St. Louis, MO) except for the following: NaCl, Na2HPO4, NaH2PO4H2O, EDTA, and glycine (Ajax Chemical Co., Sydney, Australia); sodium dodecyl sulphate (Pierce Chemical Co., Rockford, IL); KH2PO4 and D-glucose (Mallinckrodt Inc., St. Louis, MO); N-ethyl-maleimide, Di-n-butylpthalate, and dionylpthalate (BDH Chemical Co., Poole, England); and Trisacryl GF 2000 (LKB Instruments Inc., Ville Neuve, France).
Coagulation factors were of human origin. Protein C (10), protein S (7), thrombin (1 1), antithrombin III (ATIII) (12) , prothrombin, and Factor X (13) were purified and activated as previously described. All proteins were shown to be homogenous as judged by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE). Protein S was labeled with 125INa using the lodogen method (Pierce Chemical Co.), to a specific activity of 2,000 cpm/ng. The labeled protein retained functional anticoagulant activity as measured in the Factor Xa recalcification time described below.
SDS PAGE was performed according to Laemmli (14) , using a 5% stacking and a 10%1o running gel. Before application to the gel, the samples were reduced by boiling in the presence of 0.5% mercapto-ethanol.
Platelet preparation. All manipulations were performed at room temperature. The washing buffer used in this procedure was 4.3 mM K2HPO4, 4.3 mM Na2HPO4, and 24.3 mM NaH2PO42H20 (pH 6.5) containing 0.113 M NaCl and 5.5 mM glucose. To minimize platelet activation the buffer was adjusted to contain 5 mM benzamidine, 0.2 Mg/ml prostaglandin El (PGE,), 5 mM 1,3 dimethylxanthine, and 0.625 mM acetylsalicylic acid. The platelets were used within 4 h of preparation.
Blood was collected from normal human donors in 10-ml plastic tubes containing, to a final concentration, 2 mM EDTA, and the previously described inhibitors. Platelet-rich plasma, was prepared by centrifugation at 150 g for 15 min and the platelets washed as described by Baen7k-,cr and Majerus (15) . Gel-filtered platelets were prepared as described by Comp and Esmon (16) dimethylxanthine. At the following times (0, 30, 60, 120, 360, and 960 min), a 75-Ml sample was withdrawn and the platelets pelleted by centrifugation at 100,000 g for 10 min. 25 Ml ofthe supernatant was assayed for anticoagulant activity as described below, and the remainder boiled in SDS reducing buffer and electrophoresed.
Functional protein S assay. The assay is a Factor Xa recalcification time that relies upon the ability of protein S to enhance the anticoagulant activity of APC. 
Results
Experiments were undertaken to determine whether protein S binds to unstimulated platelets. These studies were performed using gel-filtered platelets or platelets washed as described in Methods. In addition benzamidine, PGE,, acetylsalicylic acid, and 1,3 dimethylxanthine were used throughout the experiments to minimize platelet activation. On phase-contrast microscopy the platelets appeared discoid and unstimulated. Fig. 1 represents a time course of specific binding of 125I-protein S to unstimulated platelets. Binding was specific, time dependent, and equilibrium was reached after 15 min. No binding occurred in the absence of Ca". The inclusion of Factor Va (2.5 nM) and or APC (25 nM) did not alter the results of the binding studies.
After binding experiments were performed the platelet pellet containing the bound protein S and the supernatant (containing the unbound protein S), were resuspended and boiled in reducing buffer and run on SDS PAGE. The unbound protein S in the supernatant appeared as a doublet identical to the starting material, whereas protein S bound to the platelet surface demonstrated cleavage ofthe upper band to the lower molecular weight peptide. When electrophoresis was performed under nonreducing conditions protein S appeared as a single band with an estimated molecular mass of 72 kD, which was identical to the starting material. These observations suggest that the cleaved portion of protein S remains attached to the remainder of the molecule by disulphide bonds.
As Fig. 3 shows, 60% of the cleaved protein S bound to the platelet surface was displaced within 20 min of the addition of 100 M excess unlabeled native protein S.
To determine whether protein S was cleaved by a surface or an internalized protease, released during activation ofthe platelet, platelet membranes and cytosol were prepared as described in (Fig. 4) demonstrated that complete cleavage of protein S occurred within 20 min. In contrast, no cleavage of 1251-protein S was observed when the protein was incubated with the cytosolic platelet components despite prolonged incubation (up to 2 h). These studies were performed in the presence and absence of saturating levels of phospholipids (platelin), with identical results obtained. When platelets were subfractionated on a sucrose density gradient as described in Methods, the protease activity resided maximally in the membrane fraction. When '25I-protein S (30 nM) was incubated for 2 h with alpha granules derived from 2 X 109/ml platelets, no cleavage was observed. Under similar conditions, platelet membranes derived from the same number of platelets resulted in cleavage of protein S after 10 min which was complete by 20 min. A concentration ten times higher ofalpha granules resulted in nearly complete cleavage of the same concentration of protein S within 2 h. The incubation of I251-protein S with red cell membranes (prepared as for platelet membranes), resulted in no cleavage of protein S, suggesting that the observed cleavage was not secondary to a nonspecific membrane effect.
To rule out the possibility that the membrane protease represented a plasma protein adsorbed to the platelet surface, we studied the ability of recalcified plasma (in the presence and absence of saturating concentrations of phospholipid) to proteolyze protein S. After 2 h incubation no cleavage of protein S could be demonstrated.
We incubated platelet membranes with protein S in the presence of APC to investigate whether APC protected its cofactor from proteolysis. The results in the first half of Fig. 5 demonstrate that APC (20 nM) neither enhanced nor inhibited the reaction. APC (20 nM) in the absence ofplatelet membranes did not cleave protein S under the experimental conditions used.
Human protein S is very sensitive to proteolytic degradation by thrombin. Because the cleavage pattern of protein S produced by the platelet membrane protease resembles thrombin-induced cleavage as judged by SDS PAGE criteria, it was essential to exclude the presence of thrombin as a possible contaminating protease in our platelet membrane preparations. To this end we studied a time course of the cleavage of '25I-protein S by the membrane protease, in the presence of 700 nM ATIII and 0.2 U/ml heparin. Cleavage of protein S again occurred within 20 min and was not impaired by the presence of the antithrombin heparin complex (second half of Fig. 5 ).
The nature of the platelet membrane protease was further investigated by the use of specific protease inhibitors. Fig. 6 represents the cumulative results of these experiments. The protease activity was inhibited by both EGTA and EDTA and by di-iso propyl fluorophosphate (50 mM), suggesting the protease is a calcium-dependent serine protease. Other agents, such as N-ethyl maleimide (NEM) (1 mM), leupeptin (1.5 mM), benzamidine (5 mM), phenyl methyl sulphonyl fluoride (PMSF) (100 nM), and the specific thrombin inhibitor, hirudin (1 U/ml), failed to inhibit the activity of the platelet membrane protease.
Activity ofplatelet membrane-cleaved protein S. This was assessed using a Factor Xa recalcification time of Al(OH)3 plasma, as described in Methods. The protein S content of the absorbed plasma was < 0. nM APC, the clotting time was prolonged by lO s. The addition of increasing concentrations of protein S resulted in a linear prolongation of the clotting time with saturation achieved in the presence of 60 nM protein S. When protein S cleaved by the platelet membrane protease (as confirmed by SDS PAGE) was substituted for intact protein S, the anticoagulant function of activated protein C was not enhanced, implying that in this form, protein S was devoid of anticoagulant activity (Fig. 7) . In other studies the loss of cofactor activity was correlated to the cleavage of protein S as assessed by SDS PAGE. Protein S was also cleaved and inactivated by intact platelets. In these studies the platelets were separated and washed as described in Methods, and incubated with protein S in the presence of0.2 ug/ml PGEI, 5 mM 1,3 dimethylxanthine, and 0.625 mM salicylic acid. However, the reaction was slower than that observed using platelet membranes. Intact platelets (1 X 10'0/ml) required 360 min to cleave and inactivate 750 nM protein S, whereas platelet membranes derived from 1 X 1010 platelets/ml, cleaved 750 nM protein S within 20 min, indicating an 18-fold increase in activity of isolated membranes over intact platelets.
Evidence that the proteolysis of protein S can occur in a plasma milieu was derived from the observation that the rate of cleavage of protein S by intact platelets or platelet membranes was unaltered by the presence or absence ofheparinized plasma.
Discussion
The results of this study demonstrate that protein S binds specifically to unstimulated platelets, with half-maximal binding at 10 nM, and an estimated 1,100 binding sites per platelet. The binding was not enhanced by prior incubation of platelets with thrombin, APC and Factor Va, alone or in combination. Harris and Esmon (19) The cleavage of protein S by platelet membranes was Ca"+ dependent because the activity was inhibited by either EDTA or EGTA. Our studies do however indicate that this protease differs from other Ca"+-dependent platelet proteases. The protease reported by Phillips et al. (21) was primarily cytosolic, was destroyed by freeze thawing and was inhibited by the sulfhydryl blocker NEM, and partially by PMSF. These characteristics contrast with the calcium-dependent protease described in this paper, which is expressed on the surface of intact platelets, is completely absent from the cytosolic compartment, and is resistant to freeze thawing, PMSF, and NEM. Tracy et al. (22) , reported a calcium-dependent protease that cleaves Factor Va, however this also appears different from the one that cleaves protein S, in that its expression was inhibited by PGE1, suggesting that it was released from internal platelet granules, and it was sensitive to the protease inhibitor, leupeptin.
By SDS PAGE criteria the cleavage ofprotein S by the membrane protease is similar to that induced by thrombin. That ATIII-heparin complex, hirudin and benzamidine did not inhibit the cleavage ofprotein S by the platelet membranes suggest that thrombin is unlikely to be the responsible protease. Furthermore, thrombin-induced cleavage of protein S is inhibited by calcium (reference 7, and our unpublished observations), whereas the platelet-associated protease is calcium dependent.
We have some evidence to indicate that both thrombin and the platelet-associated protease cleave protein S at a similar or closely associated site. When protein S cleaved by platelet membranes was incubated with thrombin, no further proteolysis could be observed. Similarly, thrombin-cleaved protein S was not susceptible to further degradation by the platelet protease (data not shown). However until the N-terminal amino acid sequence of platelet membrane-cleaved protein S is determined, comparison with the thrombin cleavage site must remain speculative.
Unlike other procoagulant and anticoagulant proteins, protein S circulates in plasma in an active form and does not require prior activation to partake in the coagulation reaction. A possible mechanism for the control of its activity has been attributed to thrombin, which cleaves protein S with subsequent loss of its anticoagulant activity. The observation that the effects of thrombin are inhibited by calcium and the endothelial cell surface protein thrombomodulin, suggests that this event is unlikely to be a major physiological control. The results of this study suggest that the platelet surface contains a novel calcium-dependent protease that may act to regulate the activity ofprotein S. The nature ofthe membrane-associated activity is the subject of our current studies.
